“METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERIDONE, QUETIAPINE, AND ARIPIPRAZOLE”. 2026. Frontier in Medical and Health Research 4 (3): 599-610. https://fmhr.net/index.php/fmhr/article/view/2481.